337 related articles for article (PubMed ID: 18806066)
1. Urethral injury during potassium-titanyl-phosphate laser prostatectomy complicated by transurethral resection syndrome.
Dilger JA; Walsh MT; Warner ME; Mynderse LA; Sprung J
Anesth Analg; 2008 Oct; 107(4):1438-40. PubMed ID: 18806066
[TBL] [Abstract][Full Text] [Related]
2. Acute renal failure after continuous flow irrigation in patients treated with potassium-titanyl-phosphate laser vaporization of prostate.
Kim MJ; Bachmann A; Mihatsch MJ; Ruszat R; Sulser T; Mayr M
Am J Kidney Dis; 2008 Apr; 51(4):e19-24. PubMed ID: 18371525
[TBL] [Abstract][Full Text] [Related]
3. Comparison of potassium-titanyl-phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-centre study.
Ruszat R; Wyler SF; Seitz M; Lehmann K; Abe C; Bonkat G; Reich O; Gasser TC; Bachmann A
BJU Int; 2008 Nov; 102(10):1432-8; discussion 1438-9. PubMed ID: 18671785
[TBL] [Abstract][Full Text] [Related]
4. Photoselective laser vaporization prostatectomy versus transurethral prostate resection: a cost analysis.
Goh AC; Gonzalez RR
J Urol; 2010 Apr; 183(4):1469-73. PubMed ID: 20172555
[TBL] [Abstract][Full Text] [Related]
5. Photoselective potassium-titanyl-phosphate (KTP) laser vaporization of the prostate (PVP) vs transurethral resection of the prostate (TURP).
Malek RS
Urology; 2008 Sep; 72(3):718-9. PubMed ID: 18597826
[No Abstract] [Full Text] [Related]
6. Laser bladder perforation from photoselective vaporization of prostate resulting in rhabdomyolysis induced acute renal failure.
Farag E; Baccala AA; Doutt RF; Ulchaker J; O'Hara J
Minerva Anestesiol; 2008 Jun; 74(6):277-80. PubMed ID: 18327155
[TBL] [Abstract][Full Text] [Related]
7. Potassium titanyl phosphate laser prostatectomy: a review.
Chandrasekera S; Muir G
Curr Opin Urol; 2007 Jan; 17(1):22-6. PubMed ID: 17143107
[TBL] [Abstract][Full Text] [Related]
8. Decreased efficiency of potassium-titanyl-phosphate laser photoselective vaporization prostatectomy with long-term 5 alpha-reductase inhibition therapy: is it true?
Araki M; Lam PN; Culkin DJ; Wong C
Urology; 2007 Nov; 70(5):927-30. PubMed ID: 18068449
[TBL] [Abstract][Full Text] [Related]
9. Greenlight laser in benign prostatic hyperplasia: turning green into gold.
Alivizatos G; Skolarikos A
Curr Opin Urol; 2008 Jan; 18(1):46-9. PubMed ID: 18090489
[TBL] [Abstract][Full Text] [Related]
10. A clinical outcomes and cost analysis comparing photoselective vaporization of the prostate to alternative minimally invasive therapies and transurethral prostate resection for the treatment of benign prostatic hyperplasia.
Stovsky MD; Griffiths RI; Duff SB
J Urol; 2006 Oct; 176(4 Pt 1):1500-6. PubMed ID: 16952668
[TBL] [Abstract][Full Text] [Related]
11. Use of expired breath ethanol measurements in evaluation of irrigant absorption during high-power potassium titanyl phosphate laser vaporization of prostate.
Barber NJ; Zhu G; Donohue JF; Thompson PM; Walsh K; Muir GH
Urology; 2006 Jan; 67(1):80-3. PubMed ID: 16413337
[TBL] [Abstract][Full Text] [Related]
12. [Intraoperative urological complications in transurethral surgical interventions on the prostate for benign hyperplasia].
Martov AG; Kornienko SI; Gushchin BL; Ergakov DV; Sazonov OA
Urologiia; 2005; (4):3-8. PubMed ID: 16158736
[TBL] [Abstract][Full Text] [Related]
13. Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70 mL: a short-term prospective randomized trial.
Horasanli K; Silay MS; Altay B; Tanriverdi O; Sarica K; Miroglu C
Urology; 2008 Feb; 71(2):247-51. PubMed ID: 18308094
[TBL] [Abstract][Full Text] [Related]
14. Vaporization of prostates of > or =80 mL using a potassium-titanyl-phosphate laser: midterm-results and comparison with prostates of <80 mL.
Pfitzenmaier J; Gilfrich C; Pritsch M; Herrmann D; Buse S; Haferkamp A; Djakovic N; Pahernik S; Hohenfellner M
BJU Int; 2008 Aug; 102(3):322-7. PubMed ID: 18422772
[TBL] [Abstract][Full Text] [Related]
15. Holmium laser enucleation of the prostate and holmium laser ablation of the prostate: indications and outcome.
Suardi N; Gallina A; Salonia A; Briganti A; Dehò F; Zanni G; Abdollah F; Naspro R; Cestari A; Guazzoni G; Rigatti P; Montorsi F
Curr Opin Urol; 2009 Jan; 19(1):38-43. PubMed ID: 19057214
[TBL] [Abstract][Full Text] [Related]
16. Instrumental treatments for benign prostatic obstruction.
Seki N; Naito S
Curr Opin Urol; 2007 Jan; 17(1):17-21. PubMed ID: 17143106
[TBL] [Abstract][Full Text] [Related]
17. [Complications of transurethral operations].
Lenkovskiĭ FM; Koraev KN
Anesteziol Reanimatol; 1985; (4):69-74. PubMed ID: 2415025
[No Abstract] [Full Text] [Related]
18. High-power potassium-titanyl-phosphate laser fibres for endovaporization of benign prostatic hyperplasia: how much do they deteriorate during the procedure?
Schwartz J; Renard J; Wolf JP; Moret M; Iselin CE
BJU Int; 2011 Jun; 107(12):1938-42. PubMed ID: 21040366
[TBL] [Abstract][Full Text] [Related]
19. Photoselective vaporization of the prostate using high power (80 W) KTP laser: one year follow up of the first 101 patients in Japan.
Hori Y; Kuromatsu I; Sugimura Y
Int J Urol; 2008 Dec; 15(12):1067-71. PubMed ID: 19054171
[TBL] [Abstract][Full Text] [Related]
20. The KTP-(greenlight-) laser--principles and experiences.
Bachmann A; Ruszat R
Minim Invasive Ther Allied Technol; 2007; 16(1):5-10. PubMed ID: 17365672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
